Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor] (2011)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- Subjects: ANTICORPOS MONOCLONAIS (TERAPIA); CRIANÇAS; LINFOMA
- Language: Inglês
- Imprenta:
- Source:
- Título: Pediatric Blood & Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: on-line, 2011
-
ABNT
VALERA, Elvis Terci et al. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 10 jan. 2026. , 2011 -
APA
Valera, E. T., Queiroz, R. G. de P., Brassesco, M. S., Scrideli, C. A., Neves, F., & Tone, L. G. (2011). Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Valera ET, Queiroz RG de P, Brassesco MS, Scrideli CA, Neves F, Tone LG. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. 2011 ;[citado 2026 jan. 10 ] -
Vancouver
Valera ET, Queiroz RG de P, Brassesco MS, Scrideli CA, Neves F, Tone LG. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. 2011 ;[citado 2026 jan. 10 ] - Inibidor de histona desacetilase LBH589 promove efeitos antineoplásicos em leucemia linfoide aguda
- Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL)
- CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?
- Effects of zebularine in childhood acute lymphoblastic Leukemia cells
- Zebularina promove diminuição da proliferação celular, apoptose e radiosensibilização em glioblastoma
- Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Expression profile of a apoptosis-related genes by real-time quantitative PCR in children with acute lymphoblastic leukemia
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
